We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+26.31%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$471M
AUM Growth
-$10.2M
Cap. Flow
-$72.7M
Cap. Flow %
-15.44%
Top 10 Hldgs %
41.74%
Holding
94
New
28
Increased
11
Reduced
21
Closed
31

Top Buys

1
TMO icon
Thermo Fisher Scientific
TMO
+$9.06M
2
XLRN
Acceleron Pharma
XLRN
+$9.03M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.53M
4
IMMU
Immunomedics Inc
IMMU
+$7.44M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$7.03M

Top Sells

1
SGEN
Seagen Inc. Common Stock
SGEN
+$15.5M
2
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$11.2M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$8.95M
4
ENDP
Endo International plc
ENDP
+$8.38M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$8.03M

Sector Composition

1 Healthcare 57.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVNC
76
DELISTED
Revance Therapeutics, Inc.
RVNC
– –
-89,295
Closed -$2.36M
CBAY
77
DELISTED
Cymabay Therapeutics
CBAY
– –
-650,000
Closed -$3.74M
SGEN
78
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-300,000
Closed -$15.5M
ACOR
79
DELISTED
Acorda Therapeutics
ACOR
– –
-3,333
Closed -$7.88M
CLVS
80
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-301,000
Closed -$28.2M
ENDP
81
DELISTED
Endo International plc
ENDP
– –
-750,000
Closed -$8.38M
EPZM
82
DELISTED
Epizyme, Inc
EPZM
– –
-150,000
Closed -$2.27M
ALXN
83
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
– –
-45,000
Closed -$5.47M
PTLA
84
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-200,000
Closed -$11.2M
PTLA
85
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
– –
-400,000
Closed -$22.5M
FOMX
86
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
– –
-125,000
Closed -$580K
BOLD
87
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-50,000
Closed -$957K
ALDR
88
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-250,000
Closed -$2.86M
NXTM
89
DELISTED
NxStage Medical Inc.
NXTM
– –
-260,000
Closed -$6.52M
TSRO
90
DELISTED
TESARO, Inc.
TSRO
– –
-50,000
Closed -$6.99M
KTWO
91
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-150,000
Closed -$3.65M
KITE
92
CALL
DELISTED
Kite Pharma, Inc.
KITE
– –
-50,000
Closed -$5.18M
NVDQ
93
DELISTED
Novadaq Technologies Inc.
NVDQ
– –
-500,000
Closed -$5.86M
SPNC
94
CALL
DELISTED
Spectranetics Corp
SPNC
– –
-200,000
Closed -$7.68M
1 2 3
4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Ghost Tree Capital held 94 positions worth $471M, down 2.1% from $481M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Ghost Tree Capital withdrew a net $72.7M in Q3 2017, closing 31 positions and reducing 21 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $15.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 58% of assets, down from 59% a quarter earlier.

Against the trend, Ghost Tree Capital opened a new position in Thermo Fisher Scientific worth $9.46M.

  • Ghost Tree Capital's largest Q3 2017 buy was Thermo Fisher Scientific: 50,000 shares worth $9.46M.
  • Ghost Tree Capital added most to Acceleron Pharma in Q3 2017, an estimated $9.03M increase.
  • Ghost Tree Capital's biggest Q3 2017 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $8.03M.
  • Ghost Tree Capital fully exited Seagen Inc. Common Stock in Q3 2017, selling an estimated $15.5M.
  • Ghost Tree Capital's ten largest holdings make up 42% of its $471M portfolio in Q3 2017.
  • Ghost Tree Capital opened 28 new positions and closed 31 in Q3 2017.
  • Ghost Tree Capital's portfolio value fell 2.1% quarter-over-quarter to $471M.

Based on Ghost Tree Capital's 13F filing for Q3 2017, filed 14 Nov 2017.